PreveCeutical Medical Inc. (CSE:PREV)

Canada flag Canada · Delayed Price · Currency is CAD
0.0300
+0.0050 (20.00%)
At close: Dec 5, 2025
20.00%
Market Cap 14.67M
Revenue (ttm) n/a
Net Income (ttm) -3.12M
Shares Out 586.81M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 565,600
Average Volume 821,395
Open 0.0250
Previous Close 0.0250
Day's Range 0.0250 - 0.0300
52-Week Range 0.0200 - 0.0600
Beta 0.16
RSI 50.24
Earnings Date Nov 28, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating ... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Stephen Van Deventer
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PREV
Full Company Profile

Financial Performance

Financial Statements

News

PreveCeutical Medical (PRVCF) Expands Private Placement to $1.2M

PreveCeutical Medical (PRVCF) Expands Private Placement to $1.2M

7 weeks ago - GuruFocus

PreveCeutical Medical boosts private placement to $1.2M, following shareholder meeting approvals

PreveCeutical Medical (PRVCF) announced that shareholders approved all resolutions presented at the Annual General and Special Meeting and upsized its previously announced private placement financing ...

7 weeks ago - Seeking Alpha